Open AccessProtocol for Symptom Experience, Management, Outcomes, and Adherence in Women Receiving Breast Cancer Chemotherapy
Author(s) -
Bethany D. Nugent,
Maura K. McCall,
Mary Connolly,
Susan R. Mazanec,
Susan M. Sereika,
Catherine M. Bender,
Margaret Rosenzweig
Publication year - 2020
Publication title -
nursing research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.577
H-Index - 91
eISSN - 1538-9847
pISSN - 0029-6562
DOI - 10.1097/nnr.0000000000000450
Subject(s) - breast cancer , medicine , incidence (geometry) , distress , cancer , chemotherapy , disease , gerontology , demography , clinical psychology , physics , sociology , optics
The 5-year survival for Black women with breast cancer in the United States is lower than White women for stage-matched disease. Our past and ongoing work and that of others suggest that symptom incidence, cancer-related distress, and ineffective communication contribute to racial disparity in dose reduction and early therapy termination. Although race is perhaps the most studied social determinant of health, it is clear that race alone does not account for all disparities.